TY  - GEN
AU  - Merkies,Ingemar S J
AU  - van Schaik,Ivo N
AU  - Léger,Jean-Marc
AU  - Bril,Vera
AU  - van Geloven,Nan
AU  - Hartung,Hans-Peter
AU  - Lewis,Richard A
AU  - Sobue,Gen
AU  - Lawo,John-Philip
AU  - Durn,Billie L
AU  - Cornblath,David R
AU  - De Bleecker,Jan L
AU  - Sommer,Claudia
AU  - Robberecht,Wim
AU  - Saarela,Mika
AU  - Kamienowski,Jerzy
AU  - Stelmasiak,Zbigniew
AU  - Tackenberg,Björn
AU  - Mielke,Orell
TI  - Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
SN  - 1529-8027
PY  - 2020///0604
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Double-Blind Method
KW  - Europe
KW  - Female
KW  - Humans
KW  - Immunoglobulins, Intravenous
KW  - administration & dosage
KW  - Immunologic Factors
KW  - Male
KW  - Middle Aged
KW  - Outcome Assessment, Health Care
KW  - Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
KW  - drug therapy
KW  - Prospective Studies
KW  - Young Adult
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/jns.12302
ER  -